Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information63
38
SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature33
31
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies30
Fusion Gene Detection in Driver Mutation‐Negative Melanomas Using RNA‐Based Anchored Multiplex Polymerase Chain Reaction29
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing28
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)23
Let’s talk about sex: A biological variable in immune response against melanoma23
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes21
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy20
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma19
Progress in melanoma treatment: Patient's perspectives16
25th International Pigment Cell Conference, Bilbao, Spain IPCC 202315
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma15
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma14
Issue Information14
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis14
Issue Information14
Issue Information14
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 613
12
Abstracts12
Issue Information12
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes12
Single‐cell profiling of MC1R‐inhibited melanocytes11
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database10
PASPCR 2024 Annual Meeting, New York, NY9
Issue Information9
9
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend9
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population8
Cover Image8
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes8
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma8
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells7
Cover Image7
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐17
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models7
Rapid Diagnosis and Subtyping of Hermansky‐Pudlak Syndrome With Flow Cytometry Analysis7
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages7
Issue Information7
7
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 20237
The delicate relation between melanocytes and skin immunity: A game of hide and seek7
Issue Information6
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment6
Topical antibiotics limit depigmentation in a mouse model of vitiligo6
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance6
Cover Image6
The metabolism of melanin synthesis—From melanocytes to melanoma6
Three‐dimensional imaging for the analysis of human epidermal melanocytes6
The Proposed Categorization of Vitiligo Lesions on the Hands6
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo6
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation6
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production6
Issue Information5
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity5
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants5
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism5
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation5
Patient Education in the Eye of the Beholder: Assessing the Effect of Skin Color Representation in Melanoma Educational Materials5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model5
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma5
Pigmentation and Retinal Pigment Epithelium Thickness: A Study of the Phenotypic and Genotypic Relationships Between Ocular and Extraocular Pigmented Tissues5
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines5
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/65
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis5
ToFSIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma5
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus4
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab4
TFE3 promotes ferroptosis in melanoma4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era4
4
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas4
4
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment4
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis4
Advancements in melanoma cancer metastasis models4
Issue Information4
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma3
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study3
YAP Upregulation Contributes to Acquired Resistance to BET Inhibitors in Uveal Melanoma3
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation3
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response3
New Dermoscopy Pattern in Nevus‐Associated Melanomas3
3
Xenopus as a model system for studying pigmentation and pigmentary disorders3
3
Optimisation of skin phototype classification3
Piceatannol—Can It Be Used to Treat Hyperpigmentation of the Skin?3
Conjunctival Melanoma: A Narrative Review of Current Knowledge3
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment3
An Integrated Investigation of SOX10 in Feather Color in Domestic Rock Pigeon (Columba livia)3
Association of Pretreatment Tumour Microenvironment and Treatment Outcome in Patients With Locally Advanced Melanoma Treated With Isolated Limb Perfusion3
Interplay of Light, Melatonin, and Circadian Genes in Skin Pigmentation Regulation3
Primary cutaneous melanoma in Black patients: An analysis of 2464 cases from the National Cancer Database 2004–20183
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy3
An in vitro nevus explant model for studying the effects of ultraviolet radiation3
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)3
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line3
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State3
Issue Information3
Myron Gordon Award Lecture 2023: Painting the neural crest: How studying pigment cells illuminates neural crest cell biology3
Chemiexcitation in Ex Vivo Porcine Skin Model3
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care2
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma2
Protein‐based classification of melanoma differentiation subtypes2
The Role of Two Tyrosinase‐Like Glycoenzymes in Defining the Final Hue of Parrot Plumage2
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations2
LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling2
The Neuro‐Endocrinal Regulation in Vitiligo2
In Memoriam: Soldano Ferrone MD, PhD (1940–2023)2
X and Y Differences in Melanoma Survival Between the Sexes2
Trained immunity in the pathogenesis of vitiligo2
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)2
Melanoma and Matrimony: Retrospective Study of Demographics, Marital Status, and Clinical Features of Patients With Acral Melanoma at a Single Academic Center2
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage2
Cover Image2
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors2
The classification of melanocytic gene signatures2
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study2
The Yucatan miniature swine as a model for post‐inflammatory hyperpigmentation2
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus1
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas1
List of reviewers for PCMR (01.01.2023–30.09.2023)1
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities1
The 21st International Congress of the Society for Melanoma Research1
List of Reviewers for PCMR1
Neurological Mechanisms Exploration and Therapeutic Targets in Segmental Vitiligo Accompanied by White Hair1
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL1
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage1
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity1
Uric acid is a major chemical constituent for the whitish coloration in the medaka leucophores1
Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children1
Genotypic spectrum of albinism in Mali1
1
Cholinergic Signaling Mediated by Muscarinic Receptors Triggers the Ultraviolet‐Induced Release of Melanosome in Cultured Melanoma Cells1
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants1
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis1
Development and Validation of Vitiligo‐Specific‐Belief About Therapy Questionnaire (BTQ‐Vitiligo)1
The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma1
Issue Information1
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma1
Cover Image1
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort1
1
Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series1
The Incorporation of Melanosomes by Senescent Keratinocytes Causes the Accumulation of Melanin due to Decreased Energy Metabolism1
Issue Information1
Cover Image1
A twenty year perspective on melanoma therapy1
The MITF regulatory network in melanoma1
Impact of Drug–Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real‐World Study1
Epilogue1
0.095933198928833